Skip to main content
. 2017 Jan 27;8(9):15220–15229. doi: 10.18632/oncotarget.14838

Figure 2. The enrichment analysis of gene profile alterations in dhC16-Cer treated PEL cells.

Figure 2

(A–B) The enrichment analysis of gene profile significantly altered (up/down ≥ 2 fold and p < 0.05) in dhC16-Cer treated BCBL-1 cells was performed using the Metacore Software (Thompson Reuters) Modules: Gene Ontology Processes (A) and Process Networks (B).